Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure-based design of targeted covalent inhibitors
Richard Lonsdale, Richard A. Ward
Chemical Society Reviews (2018) Vol. 47, Iss. 11, pp. 3816-3830
Closed Access | Times Cited: 291

Showing 26-50 of 291 citing articles:

Discovery of Cysteine-targeting Covalent Protein Kinase Inhibitors
Xiaoyun Lu, Jeff B. Smaill, Adam V. Patterson, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 1, pp. 58-83
Closed Access | Times Cited: 90
Covalent fragment libraries in drug discovery
Aaron Keeley, László Petri, Péter Ábrányi‐Balogh, et al.
Drug Discovery Today (2020) Vol. 25, Iss. 6, pp. 983-996
Open Access | Times Cited: 89
Covalent Small Molecules as Enabling Platforms for Drug Discovery
Samuel E. Dalton, Sébastien Campos
ChemBioChem (2019) Vol. 21, Iss. 8, pp. 1080-1100
Closed Access | Times Cited: 81
The design and development of covalent protein-protein interaction inhibitors for cancer treatment
Shasha Cheng, Guan‐Jun Yang, Wanhe Wang, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 80
Mix-and-inject XFEL crystallography reveals gated conformational dynamics during enzyme catalysis
Medhanjali Dasgupta, Dominik Budday, Saulo H. P. de Oliveira, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 51, pp. 25634-25640
Open Access | Times Cited: 77
An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 Mpro inhibitor
Daniel Zaidman, Paul Gehrtz, Mihajlo Filep, et al.
Cell chemical biology (2021) Vol. 28, Iss. 12, pp. 1795-1806.e5
Open Access | Times Cited: 73
Avoiding Drug Resistance in HIV Reverse Transcriptase
Maria E. Cilento, Karen A. Kirby, Stefan G. Sarafianos
Chemical Reviews (2021) Vol. 121, Iss. 6, pp. 3271-3296
Open Access | Times Cited: 68
FLT3 Inhibitors in Acute Myeloid Leukemia: Challenges and Recent Developments in Overcoming Resistance
Zhijie Wang, Jiongheng Cai, Jie Cheng, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 6, pp. 2878-2900
Closed Access | Times Cited: 64
Contemporary Medicinal Chemistry Strategies for the Discovery and Development of Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors
Zhao Wang, Srinivasulu Cherukupalli, Minghui Xie, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 5, pp. 3729-3757
Open Access | Times Cited: 50
Robust Covalent Aptamer Strategy Enables Sensitive Detection and Enhanced Inhibition of SARS-CoV-2 Proteins
Dan Wang, Jing Zhang, Zhiyong Huang, et al.
ACS Central Science (2023) Vol. 9, Iss. 1, pp. 72-83
Open Access | Times Cited: 40
Fragment-based drug discovery supports drugging ‘undruggable’ protein–protein interactions
Zhi-Zheng Wang, Xing-Xing Shi, Guang-Yi Huang, et al.
Trends in Biochemical Sciences (2023) Vol. 48, Iss. 6, pp. 539-552
Closed Access | Times Cited: 26
Development of covalent inhibitors: Principle, design, and application in cancer
Lang Zheng, Yang Li, Defa Wu, et al.
MedComm – Oncology (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 25
Biospecific Chemistry for Covalent Linking of Biomacromolecules
Li Cao, Lei Wang
Chemical Reviews (2024) Vol. 124, Iss. 13, pp. 8516-8549
Open Access | Times Cited: 11
New insights into protein–protein interaction modulators in drug discovery and therapeutic advance
Hossam Nada, Yongseok Choi, Sung-Do Kim, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Inhibitors of Immune Checkpoints: Small Molecule- and Peptide-Based Approaches
Natalie Fuchs, Longfei Zhang, Laura Calvo‐Barreiro, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 1, pp. 68-68
Open Access | Times Cited: 10
Design and characterization of a heterocyclic electrophilic fragment library for the discovery of cysteine-targeted covalent inhibitors
Aaron Keeley, Péter Ábrányi‐Balogh, György M. Keserü
MedChemComm (2018) Vol. 10, Iss. 2, pp. 263-267
Open Access | Times Cited: 75
Revisiting signal transducer and activator of transcription 3 (STAT3) as an anticancer target and its inhibitor discovery: Where are we and where should we go?
Qiuyao Huang, Yan Zhong, Hui Dong, et al.
European Journal of Medicinal Chemistry (2019) Vol. 187, pp. 111922-111922
Closed Access | Times Cited: 73
Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRASG12C
Jason G. Kettle, Sharan K. Bagal, Sue Bickerton, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 9, pp. 4468-4483
Closed Access | Times Cited: 67
Vinylphosphonites for Staudinger-induced chemoselective peptide cyclization and functionalization
Marc‐André Kasper, Maria Glanz, Andreas Oder, et al.
Chemical Science (2019) Vol. 10, Iss. 25, pp. 6322-6329
Open Access | Times Cited: 59
Nucleophilicity of Glutathione: A Link to Michael Acceptor Reactivities
Robert J. Mayer, Armin R. Ofial
Angewandte Chemie International Edition (2019) Vol. 58, Iss. 49, pp. 17704-17708
Open Access | Times Cited: 57
Covalent Versus Non-covalent Enzyme Inhibition: Which Route Should We Take? A Justification of the Good and Bad from Molecular Modelling Perspective
Aimen Aljoundi, Imane Bjij, Ahmed El Rashedy, et al.
The Protein Journal (2020) Vol. 39, Iss. 2, pp. 97-105
Closed Access | Times Cited: 57
Visible‐Light‐Induced Cysteine‐Specific Bioconjugation: Biocompatible Thiol–Ene Click Chemistry
Hangyeol Choi, Myojeong Kim, Jaebong Jang, et al.
Angewandte Chemie International Edition (2020) Vol. 59, Iss. 50, pp. 22514-22522
Closed Access | Times Cited: 57
CovalentInDB: a comprehensive database facilitating the discovery of covalent inhibitors
Hongyan Du, Junbo Gao, Gaoqi Weng, et al.
Nucleic Acids Research (2020) Vol. 49, Iss. D1, pp. D1122-D1129
Open Access | Times Cited: 57
Enhanced Suppression of a Protein–Protein Interaction in Cells Using Small-Molecule Covalent Inhibitors Based on an N-Acyl-N-alkyl Sulfonamide Warhead
Tsuyoshi Ueda, Tomonori Tamura, Masaharu Kawano, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 12, pp. 4766-4774
Open Access | Times Cited: 56
Alkynyl Benzoxazines and Dihydroquinazolines as Cysteine Targeting Covalent Warheads and Their Application in Identification of Selective Irreversible Kinase Inhibitors
Kirsten McAulay, Emily Hoyt, Morgan Thomas, et al.
Journal of the American Chemical Society (2020) Vol. 142, Iss. 23, pp. 10358-10372
Open Access | Times Cited: 54

Scroll to top